The quantitative real-time polymerase chain reaction (PCR) analysis of peripheral blood samples detected the presence of BCR-ABL fusion transcripts, thus establishing the diagnosis of chronic-phase chronic myeloid leukemia (CML). The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.